As a caveat, these in vitro experiments were co-cultures of T cells and dendritic cells, so it is still unknown if FXR antagonism at dendritic cells at the in vivo scale is more important for IBD pathogenesis compared to well-known potent general gut anti-inflammatory FXR agonism. The gene discussed is NR1H4; the disease is inflammatory bowel disease.